Outcomes of Emergency Transcatheter Aortic Valve Replacement

Table 1

Baseline demographic and clinical characteristics of patients undergoing emergency transcatheter aortic valve replacement.

Demographics
Age (years), mean (SD)	73.1 (13.9)
Male gender, n (%)	23 (74.2)
BSA (kg/m^2), mean (SD)	1.94 (0.24)
Race
White, n (%)	22 (71.0)
Black, n (%)	1 (3.2)
Hispanic, n (%)	2 (6.5)
Asian, n (%)	3 (9.7)
Other/unknown, n (%)	3 (9.7)
History and Risk Factors
Current/recent smoker, n (%)	6 (19.4)
Hypertension, n (%)	25 (80.6)
Diabetes mellitus, n (%)	12 (38.7)
Peripheral artery disease, n (%)	4 (12.9)
Atrial fibrillation, n (%)	15 (51.6)
Coronary artery disease, n (%)	21 (67.7)
Chronic kidney disease (GFR <60 ml/min; not on HD), n (%)	12 (38.7)
Chronic kidney disease on HD, n (%)	2 (6.5)
COPD, n (%)	3 (9.7)
Severe COPD, n (%)	1 (3.2)
Prior PCI, n (%)	10 (32.3)
Prior CABG, n (%)	6 (19.4)
Prior sternotomy, n (%)	7 (22.6)
Prior SAVR, n (%)	5 (16.1)
Prior stroke, n (%)	1 (3.2)
Immunocompromise, n (%)	2 (6.5)
Known history of CHF, n (%)	26 (83.9)
Preprocedure Status
Prior MI, n (%)	22 (71.0)
Cardiogenic shock within 24 hours, n (%)	26 (83.9)
ACS at hospital presentation, n (%)	15 (48.4)
ACS at time of TAVR, n (%)	12 (38.7)
Heart rate (beats/min), mean (SD)	92.7 (20.1)
BNP (pg/mL), mean (SD)	2217.0 (1759.2)
Creatinine (mg/dL), mean (SD)	1.56 (1.23)
Intubated, n (%)	12 (38.7)

BSA: body surface area; GFR: glomerular filtration rate; HD: hemodialysis; COPD: chronic obstructive pulmonary disease; PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting; SAVR: surgical aortic valve replacement; CHF: congestive heart failure; MI: myocardial infarction; ACS: acute coronary syndrome; TAVR: transcatheter aortic valve replacement; BNP: B-type natriuretic peptide.